ClinicalTrials.gov
ClinicalTrials.gov Menu

Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00579267
Recruitment Status : Completed
First Posted : December 24, 2007
Last Update Posted : February 16, 2009
Sponsor:
Information provided by:
University of South Florida

Brief Summary:

The primary aims of this study are to assess:

  1. The inter-rater and test-retest reliability of the MINI-KID
  2. The validity of the standard MINI-KID interview in relation to the parent rated pencil/paper version (MINI-KID-P) and th longer clinician rated "Schedule for Affective Disorders and Schizophrenia for School Aged Children-Present and Lifetime Version (K-SADS-PL) and "expert opinion" (when available).

Secondary aims will include evaluating the concordance between: The Children's Global Assessment Scale (a required part of the K-SADS) with the clinician-rated Sheehan Disability Scale (to be administered with the MINI-KID) as a measure of illness severity.


Condition or disease Intervention/treatment
Major Depression Mania Anxiety Disorders Psychotic Disorder Alcohol Dependence Drug Dependence Eating Disorders Suicidality Dysthymia ADHD Tourettes Disorder Conduct Disorder Oppositional Defiant Disorder Pervasive Developmental Disorder Other: MINI-KID

Detailed Description:

The MINI-KID is a short, structured diagnostic interview used to assess the presence of 24 DSM-IV child and adolescent psychiatric disorders as well as the risk of suicide.

To achieve adequate representation of the major psychiatric disorders and sufficient normal controls, we propose recruiting 230 children and adolescents (ages 6 to 17 years 11 months), comprised of 200 subjects identified as having one or more psychiatric disorders and 30 normal controls in the community. These subjects will be from diverse socioeconomic, racial and ethnic backgrounds. We will assess the inter-rater and test-retest reliability of the MINI-KID and examine its validity with the "gold-standard" diagnostic interview for children and adolescents as well as expert opinion.


Study Type : Observational
Actual Enrollment : 230 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
Study Start Date : February 2004
Actual Primary Completion Date : January 2008
Actual Study Completion Date : January 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources


Intervention Details:
    Other: MINI-KID
    Structured Diagnostic Interview for children and adolescent psychiatric disorders.


Primary Outcome Measures :
  1. Kappa scores between MINI Kid and K-SADS [ Time Frame: 4 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   6 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Children and adolescents between the ages of 6 and 18 years.
Criteria

Inclusion Criteria:

  • Subjects will be between the ages of 6 years and 17 years, 11 months
  • All subjects must meet MINI-KID DSM-IV criteria for a least one of the Axis I child psychiatry disorders covered by the MINI-KID.
  • Both sexes are included.

Exclusion Criteria:

  • Subjects who suffer from mental retardation, significant developmental disorders, congenital abnormalities, delirium, dementia, a language problem, or brain damage will be excluded.
  • Subjects with neurological disorders, chronic or life threatening diseases will be excluded.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00579267


Locations
United States, Florida
University of South Florida College of Medicine, Department of Psychiatry
Tampa, Florida, United States, 33613-4788
Sponsors and Collaborators
University of South Florida
Investigators
Principal Investigator: David V. Sheehan, MD, MBA University of South Florida College of Medicine

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: David V. Sheehan, MD, MBA, University of South Florida College of Medicine
ClinicalTrials.gov Identifier: NCT00579267     History of Changes
Other Study ID Numbers: MINI-KID Validation Study
First Posted: December 24, 2007    Key Record Dates
Last Update Posted: February 16, 2009
Last Verified: December 2007

Keywords provided by University of South Florida:
MINI-KID
structured diagnostic interview
reliability and validity
K-SADS
Sheehan Disability Scale

Additional relevant MeSH terms:
Disease
Anxiety Disorders
Depressive Disorder, Major
Alcoholism
Feeding and Eating Disorders
Psychotic Disorders
Mental Disorders
Developmental Disabilities
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Autistic Disorder
Conduct Disorder
Substance-Related Disorders
Tourette Syndrome
Attention Deficit and Disruptive Behavior Disorders
Pathologic Processes
Depressive Disorder
Mood Disorders
Alcohol-Related Disorders
Chemically-Induced Disorders
Schizophrenia Spectrum and Other Psychotic Disorders
Neurodevelopmental Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tic Disorders
Movement Disorders
Heredodegenerative Disorders, Nervous System
Neurodegenerative Diseases